SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients is a research paper published in NAR Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA178999
NIH
Grant: R01CA178999S1
NIH
Grant: R01CA254403
NIH
Grant: R01CA254403-04S1
NIH
Grant: R01CA254403-04S2
NIH
Grant: U54CA274513
NIH
Grant: CA160771
NIH
Grant: K01CA226346
NIAID
Grant: R01AI162633
NIAID
Grant: R01AI136581
NCI NIH HHS
Grant: R01 CA160771
National Institutes of Health
Grant: 7R01CA160771-05
See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization DrugDelivery
National Institutes of Health
Grant: 5R01CA178999-02
Mechanisms of SIRT2 Function in the Replication Stress Response
National Institutes of Health
Grant: 3U54CA274513-04S1
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
National Institutes of Health
Grant: 5R01AI136581-07
Lentivirus Replication Strategy and Pathogenesis
National Institutes of Health
Grant: 7K01CA226346-03
Understanding mechanistic role of SAMHD1 in DNA damage response and therapeutic benefit for malignant glioma
National Institutes of Health
Grant: 5R01CA254403-03
Elucidating SAMHD1 in DNA Double-Strand Break Repair
National Institutes of Health
Grant: 5R01AI162633-03
SAMHD1 mediated dNTP regulation and HIV in myeloid cells
NCI
FWCI
1.02
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords